Follow
Alicia Kraay
Alicia Kraay
Unknown affiliation
Verified email at umich.edu
Title
Cited by
Cited by
Year
Fomite-mediated transmission as a sufficient pathway: a comparative analysis across three viral pathogens
ANM Kraay, MAL Hayashi, N Hernandez-Ceron, IH Spicknall, ...
BMC infectious diseases 18, 1-13, 2018
1532018
Estimating the cumulative incidence of SARS-CoV-2 infection and the infection fatality ratio in light of waning antibodies
K Shioda, MSY Lau, ANM Kraay, KN Nelson, AJ Siegler, PS Sullivan, ...
Epidemiology 32 (4), 518-524, 2021
772021
Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world
J Toor, S Echeverria-Londono, X Li, K Abbas, ED Carter, HE Clapham, ...
Elife 10, e67635, 2021
692021
Understanding the impact of rainfall on diarrhea: testing the concentration-dilution hypothesis using a systematic review and meta-analysis
ANM Kraay, O Man, MC Levy, K Levy, E Ionides, JNS Eisenberg
Environmental health perspectives 128 (12), 126001, 2020
652020
Modeling environmentally mediated rotavirus transmission: The role of temperature and hydrologic factors
ANM Kraay, AF Brouwer, N Lin, PA Collender, JV Remais, JNS Eisenberg
Proceedings of the National Academy of Sciences 115 (12), E2782-E2790, 2018
522018
Risk for fomite-mediated transmission of SARS-CoV-2 in child daycares, schools, nursing homes, and offices
ANM Kraay, MAL Hayashi, DM Berendes, JS Sobolik, JS Leon, ...
Emerging Infectious Diseases 27 (4), 1229, 2021
492021
Impact of nonpharmaceutical interventions for severe acute respiratory syndrome coronavirus 2 on norovirus outbreaks: an analysis of outbreaks reported by 9 US states
ANM Kraay, P Han, AK Kambhampati, ME Wikswo, SA Mirza, BA Lopman
The Journal of infectious diseases 224 (1), 9-13, 2021
462021
Indirect benefits are a crucial consideration when evaluating SARS-CoV-2 vaccine candidates
ME Gallagher, AJ Sieben, KN Nelson, ANM Kraay, WA Orenstein, ...
Nature medicine 27 (1), 4-5, 2021
362021
Decontamination of SARS-CoV-2 from cold-chain food packaging provides no marginal benefit in risk reduction to food workers
JS Sobolik, ET Sajewski, LA Jaykus, DK Cooper, BA Lopman, ANM Kraay, ...
Food Control 136, 108845, 2022
212022
Modeling serological testing to inform relaxation of social distancing for COVID-19 control
ANM Kraay, KN Nelson, CY Zhao, D Demory, JS Weitz, BA Lopman
Nature communications 12 (1), 7063, 2021
212021
Controlling risk of SARS-CoV-2 infection in essential workers of enclosed food manufacturing facilities
JS Sobolik, ET Sajewski, LA Jaykus, DK Cooper, BA Lopman, ANM Kraay, ...
Food Control 133, 108632, 2022
202022
Considering indirect benefits is critical when evaluating SARS-CoV-2 vaccine candidates
ME Gallagher, AJ Sieben, KN Nelson, ANM Kraay, B Lopman, A Handel, ...
medRxiv, 2020
162020
Determinants of short-term movement in a developing region and implications for disease transmission
ANM Kraay, J Trostle, AF Brouwer, W Cevallos, JNS Eisenberg
Epidemiology 29 (1), 117-125, 2018
162018
Risk of fomite-mediated transmission of SARS-CoV-2 in child daycares, schools, and offices: a modeling study
ANM Kraay, MAL Hayashi, DM Berendes, JS Sobolik, JS Leon, ...
MedRxiv, 2020.08. 10.20171629, 2020
152020
Characterizing dengue transmission in rural areas: A systematic review
O Man, A Kraay, R Thomas, J Trostle, GO Lee, C Robbins, AC Morrison, ...
PLoS neglected tropical diseases 17 (6), e0011333, 2023
82023
Impact of non-pharmaceutical interventions for SARS-CoV-2 on Norovirus outbreaks: an analysis of outbreaks reported by 9 US states
ANM Kraay, P Han, AK Kambhampati, ME Wikswo, SA Mirza, BA Lopman
MedRxiv, 2020.11. 25.20237115, 2020
82020
Predicting norovirus and rotavirus resurgence in the United States following the COVID-19 pandemic: a mathematical modelling study
BL Lappe, ME Wikswo, AK Kambhampati, SA Mirza, JE Tate, ANM Kraay, ...
BMC Infectious Diseases 23 (1), 254, 2023
62023
Low risk of SARS-CoV-2 transmission via fomite, even in cold-chain
JS Sobolik, ET Sajewski, LA Jaykus, DK Cooper, BA Lopman, ANM Kraay, ...
medRxiv, 2021
52021
Modeling the use of SARS-CoV-2 vaccination to safely relax non-pharmaceutical interventions
ANM Kraay, ME Gallagher, Y Ge, P Han, JM Baker, K Koelle, A Handel, ...
MedRxiv, 2021.03. 12.21253481, 2021
52021
Effect of childhood rotavirus vaccination on community rotavirus prevalence in rural Ecuador, 2008-13
ANM Kraay, EL Ionides, GO Lee, WFC Trujillo, JNS Eisenberg
International journal of epidemiology 49 (5), 1691-1701, 2020
52020
The system can't perform the operation now. Try again later.
Articles 1–20